Abstract
While lifestyle modifications should be the first-line actions in preventing and treating obesity and eating disorders, pharmacotherapy also provides a necessary tool for the management of these diseases.
However, given the limitations of current anti-obesity drugs, innovative treatments that improve efficacy and safety are needed.
Since the discovery that the activation of the Nociceptin/Orphanin (N/OFQ) FQ peptide (NOP) receptor by N/OFQ induces an increase of food intake in laboratory animals, and the finding that this effect can be blocked by NOP antagonists, many NOP agonists and antagonists have been synthesized and tested in vitro and in vivo for their potential regulation of feeding behavior. Promising results seem to suggest that the N/OFQergic system may be a potential therapeutic target for the neural control of feeding behavior and related pathologies, especially in binge-like eating behavior.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Agostini S, Petrella C (2014) The endogenous nociceptin/orphanin FQ-NOP receptor system as a potential therapeutic target for intestinal disorders. Neurogastroenterol Motil 26:1519–1526. https://doi.org/10.1111/nmo.12460
Agostini S, Eutamene H, Broccardo M, Improta G, Petrella C, Theodorou V, Bueno L (2009) Peripheral anti-nociceptive effect of nociceptin/orphanin FQ in inflammation and stress-induced colonic hyperalgesia in rats. Pain 141:292–299. https://doi.org/10.1016/j.pain.2008.12.007
Amianto F, Ottone L, Abbate Daga G, Fassino S (2015) Binge-eating disorder diagnosis and treatment: a recap in front of DSM-5. BMC Psychiatry 15:70. https://doi.org/10.1186/s12888-015-0445-6
Anton B, Fein J, To T, Li X, Silberstein L, Evans CJ (1996) Immunohistochemical localization of ORL-1 in the central nervous system of the rat. J Comp Neurol 368:229–251. https://doi.org/10.1002/(SICI)1096-9861(19960429)368:2<229::AID-CNE5>3.0.CO;2-5
Blasio A et al (2013) Rimonabant precipitates anxiety in rats withdrawn from palatable food: role of the central amygdala. Neuropsychopharmacology 38:2498–2507. https://doi.org/10.1038/npp.2013.153
Bodnar RJ (1998) Recent advances in the understanding of the effects of opioid agents on feeding and appetite. Expert Opin Investig Drugs 7:485–497. https://doi.org/10.1517/13543784.7.4.485
Bomberg EM, Grace MK, Levine AS, Olszewski PK (2006) Functional interaction between nociceptin/orphanin FQ and alpha-melanocyte-stimulating hormone in the regulation of feeding. Peptides 27:1827–1834. https://doi.org/10.1016/j.peptides.2006.02.007
Brookes ZL, Stedman EN, Guerrini R, Lawton BK, Calo G, Lambert DG (2007) Proinflammatory and vasodilator effects of nociceptin/orphanin FQ in the rat mesenteric microcirculation are mediated by histamine. Am J Phys Heart Circ Phys 293:H2977–H2985. https://doi.org/10.1152/ajpheart.00448.2007
Bulik CM, Sullivan PF, Kendler KS (1998) Heritability of binge-eating and broadly defined bulimia nervosa. Biol Psychiatry 44:1210–1218. https://doi.org/10.1016/S0006-3223(98)00280-7
Bulik CM, Sullivan PF, Kendler KS (2003) Genetic and environmental contributions to obesity and binge eating. Int J Eat Disord 33:293–298. https://doi.org/10.1002/eat.10140
Calo G, Guerrini R, Bigoni R, Rizzi A, Bianchi C, Regoli D, Salvadori S (1998) Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist. J Med Chem 41:3360–3366. https://doi.org/10.1021/jm970805q
Calo G et al (2011) UFP-112 a potent and long-lasting agonist selective for the nociceptin/orphanin FQ receptor. CNS Neurosci Ther 17:178–198. https://doi.org/10.1111/j.1755-5949.2009.00107.x
Ciccocioppo R, Martin-Fardon R, Weiss F, Massi M (2001) Nociceptin/orphanin FQ inhibits stress- and CRF-induced anorexia in rats. Neuroreport 12:1145–1149. https://doi.org/10.1097/00001756-200105080-00019
Ciccocioppo R, Biondini M, Antonelli L, Wichmann J, Jenck F, Massi M (2002) Reversal of stress- and CRF-induced anorexia in rats by the synthetic nociceptin/orphanin FQ receptor agonist, Ro 64-6198. Psychopharmacology 161:113–119. https://doi.org/10.1007/s00213-002-1020-7
Ciccocioppo R, Fedeli A, Economidou D, Policani F, Weiss F, Massi M (2003) The bed nucleus is a neuroanatomical substrate for the anorectic effect of corticotropin-releasing factor and for its reversal by nociceptin/orphanin FQ. J Neurosci 23:9445–9451. https://doi.org/10.1523/JNEUROSCI.23-28-09445.2003
Cifani C, Polidori C, Melotto S, Ciccocioppo R, Massi M (2009) A preclinical model of binge eating elicited by yo-yo dieting and stressful exposure to food: effect of sibutramine, fluoxetine, topiramate, and midazolam. Psychopharmacology 204:113–125. https://doi.org/10.1007/s00213-008-1442-y
Cifani C, Di Bonaventura MVM, Ciccocioppo R, Massi M (2013) Binge eating in female rats induced by yo-yo dieting and stress. In: Avena NM (ed) Animal models of eating disorders. Springer, Berlin, pp 27–49
Costentin J, Florin S, Suaudeau C, Meunier JC (1998) [Cloning of prepronociceptin has led to the discovery of other biologically active peptides] Comptes rendus des seances de la Societe de biologie et de ses filiales 192:1099–1109
Cottone P et al (2009) CRF system recruitment mediates dark side of compulsive eating. Proc Natl Acad Sci U S A 106:20016–20020. https://doi.org/10.1073/pnas.0908789106
Cox BM, Christie MJ, Devi L, Toll L, Traynor JR (2015) Challenges for opioid receptor nomenclature: IUPHAR Review 9. Br J Pharmacol 172:317–323. https://doi.org/10.1111/bph.12612
Cusin I, Rohner-Jeanrenaud F, Stricker-Krongrad A, Jeanrenaud B (1996) The weight-reducing effect of an intracerebroventricular bolus injection of leptin in genetically obese fa/fa rats. Reduced sensitivity compared with lean animals. Diabetes 45:1446–1450. https://doi.org/10.2337/diabetes.45.10.1446
D’Addario C et al (2014) Endocannabinoid signaling and food addiction. Neurosci Biobehav Rev 47:203–224. https://doi.org/10.1016/j.neubiorev.2014.08.008
Dingemans AE, Bruna MJ, van Furth EF (2002) Binge eating disorder: a review. Int J Obes Relat Metab Disord 26:299–307. https://doi.org/10.1038/sj.ijo.0801949
Drewnowski A (1995) Metabolic determinants of binge eating. Addict Behav 20:733–745. https://doi.org/10.1016/0306-4603(95)00105-0
Economidou D, Policani F, Angellotti T, Massi M, Terada T, Ciccocioppo R (2006) Effect of novel NOP receptor ligands on food intake in rats. Peptides 27:775–783. https://doi.org/10.1016/j.peptides.2005.08.014
Emmerson PJ, Miller RJ (1999) Pre- and postsynaptic actions of opioid and orphan opioid agonists in the rat arcuate nucleus and ventromedial hypothalamus in vitro. J Physiol 517(Pt 2):431–445. https://doi.org/10.1111/j.1469-7793.1999.0431t.x
Farhang B, Pietruszewski L, Lutfy K, Wagner EJ (2010) The role of the NOP receptor in regulating food intake, meal pattern, and the excitability of proopiomelanocortin neurons. Neuropharmacology 59:190–200. https://doi.org/10.1016/j.neuropharm.2010.05.007
Ferrari W (1958) Behavioural changes in animals after intracisternal injection with adrenocorticotrophic hormone and melanocyte-stimulating hormone. Nature 181:925–926. https://doi.org/10.1038/181925a0
Filaferro M et al (2014) Functional antagonism between nociceptin/orphanin FQ and corticotropin-releasing factor in rat anxiety-related behaviors: involvement of the serotonergic system. Neuropeptides 48:189–197. https://doi.org/10.1016/j.npep.2014.05.001
Filippetti R, Kloting I, Massi M, Cifani C, Polidori C (2007) Involvement of cocaine-amphetamine regulated transcript in the differential feeding responses to nociceptin/orphanin FQ in dark agouti and Wistar Ottawa Karlsburg W rats. Peptides 28:1966–1973. https://doi.org/10.1016/j.peptides.2007.08.003
Foltin RW, Brady JV, Fischman MW (1986) Behavioral analysis of marijuana effects on food intake in humans. Pharmacol Biochem Behav 25:577–582. https://doi.org/10.1016/0091-3057(86)90144-9
Fullerton DT, Getto CJ, Swift WJ, Carlson IH (1985) Sugar, opioids and binge eating. Brain Res Bull 14:673–680. https://doi.org/10.1016/0361-9230(85)90117-0
Gavioli EC, Calo G (2006) Antidepressant- and anxiolytic-like effects of nociceptin/orphanin FQ receptor ligands. Naunyn Schmiedeberg’s Arch Pharmacol 372:319–330. https://doi.org/10.1007/s00210-006-0035-8
Giugliano D, Lefebvre PJ (1991) A role for beta-endorphin in the pathogenesis of human obesity? Horm Metab Res 23:251–256. https://doi.org/10.1055/s-2007-1003667
Gosnell BA, Levine AS, Morley JE (1986) The stimulation of food intake by selective agonists of mu, kappa and delta opioid receptors. Life Sci 38:1081–1088. https://doi.org/10.1016/0024-3205(86)90243-2
Guerrini R, Calo G, Bigoni R, Rizzi D, Regoli D, Salvadori S (2001) Structure-activity relationship of [Nphe1]-NC-(1-13)-NH2, a pure and selective nociceptin/orphanin FQ receptor antagonist. J Pept Res 57:215–222. https://doi.org/10.1111/j.1399-3011.2001.00820.x
Guerrini R et al (2014) A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ. Bioorg Med Chem 22:3703–3712. https://doi.org/10.1016/j.bmc.2014.05.005
Gunduz O et al (2006) In vitro and in vivo pharmacological characterization of the nociceptin/orphanin FQ receptor ligand Ac-RYYRIK-ol. Eur J Pharmacol 539:39–48. https://doi.org/10.1016/j.ejphar.2006.03.075
Hardaway JA et al (2016) Nociceptin receptor antagonist SB 612111 decreases high fat diet binge eating. Behav Brain Res 307:25–34. https://doi.org/10.1016/j.bbr.2016.03.046
Hardaway JA, Boyt K, Martin WJ, Wallace TL, Kash T (2018) Characterization of the nociceptin system in neural circuits underlying highly palatable food intake as a model of reward. Program No. 648.23. 2018 Neuroscience Meeting Planner. Society for Neuroscience, San Diego. Online
Hashimoto Y, Calo G, Guerrini R, Smith G, Lambert DG (2000) Antagonistic effects of [Nphe1]nociceptin(1-13)NH2 on nociceptin receptor mediated inhibition of cAMP formation in Chinese hamster ovary cells stably expressing the recombinant human nociceptin receptor. Neurosci Lett 278:109–112. https://doi.org/10.1016/S0304-3940(99)00915-5
Jenck F et al (2000) A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: anxiolytic profile in the rat. Proc Natl Acad Sci U S A 97:4938–4943. https://doi.org/10.1073/pnas.090514397
Joseph T et al (2006) Identification of mature nocistatin and nociceptin in human brain and cerebrospinal fluid by mass spectrometry combined with affinity chromatography and HPLC. Peptides 27:122–130. https://doi.org/10.1016/j.peptides.2005.06.013
Kaye WH, Pickar D, Naber D, Ebert MH (1982) Cerebrospinal fluid opioid activity in anorexia nervosa. Am J Psychiatry 139:643–645. https://doi.org/10.1176/ajp.139.5.643
Koizumi M, Cagniard B, Murphy NP (2009) Endogenous nociceptin modulates diet preference independent of motivation and reward. Physiol Behav 97:1–13. https://doi.org/10.1016/j.physbeh.2008.12.008
Lee YS et al (2008) Opioid and melanocortin receptors: do they have overlap** pharmacophores? Biopolymers 90:433–438. https://doi.org/10.1002/bip.20814
Leibowitz SF, Hor L (1982) Endorphinergic and alpha-noradrenergic systems in the paraventricular nucleus: effects on eating behavior. Peptides 3:421–428. https://doi.org/10.1016/0196-9781(82)90102-4
Leventhal L, Mathis JP, Rossi GC, Pasternak GW, Bodnar RJ (1998) Orphan opioid receptor antisense probes block orphanin FQ-induced hyperphagia. Eur J Pharmacol 349:R1–R3. https://doi.org/10.1016/S0014-2999(98)00272-6
Margules DL, Moisset B, Lewis MJ, Shibuya H, Pert CB (1978) Beta-endorphin is associated with overeating in genetically obese mice (ob/ob) and rats (fa/fa). Science 202:988–991. https://doi.org/10.1126/science.715455
Matsushita H et al (2009) Chronic intracerebroventricular infusion of nociceptin/orphanin FQ produces body weight gain by affecting both feeding and energy metabolism in mice. Endocrinology 150:2668–2673. https://doi.org/10.1210/en.2008-1515
McKay LD, Kenney NJ, Edens NK, Williams RH, Woods SC (1981) Intracerebroventricular beta-endorphin increases food intake of rats. Life Sci 29:1429–1434. https://doi.org/10.1016/0024-3205(81)90006-0
McLean S, Hoebel BG (1983) Feeding induced by opiates injected into the paraventricular hypothalamus. Peptides 4:287–292. https://doi.org/10.1016/0196-9781(83)90134-1
Meunier JC et al (1995) Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 377:532–535. https://doi.org/10.1038/377532a0
Micioni Di Bonaventura MV, Cifani C, Lambertucci C, Volpini R, Cristalli G, Massi M (2012) A2A adenosine receptor agonists reduce both high-palatability and low-palatability food intake in female rats. Behav Pharmacol 23:567–574. https://doi.org/10.1097/FBP.0b013e3283566a60
Micioni Di Bonaventura MV, Ubaldi M, Liberati S, Ciccocioppo R, Massi M, Cifani C (2013) Caloric restriction increases the sensitivity to the hyperphagic effect of nociceptin/orphanin FQ limiting its ability to reduce binge eating in female rats. Psychopharmacology 228:53–63. https://doi.org/10.1007/s00213-013-3013-0
Micioni Di Bonaventura MV et al (2014) Role of bed nucleus of the stria terminalis corticotrophin-releasing factor receptors in frustration stress-induced binge-like palatable food consumption in female rats with a history of food restriction. J Neurosci 34:11316–11324. https://doi.org/10.1523/JNEUROSCI.1854-14.2014
Micioni Di Bonaventura MV, Ubaldi M, Giusepponi ME, Rice KC, Massi M, Ciccocioppo R, Cifani C (2017) Hypothalamic CRF1 receptor mechanisms are not sufficient to account for binge-like palatable food consumption in female rats. Int J Eat Disord 50:1194–1204. https://doi.org/10.1002/eat.22767
Morley JE, Levine AS (1983) Involvement of dynorphin and the kappa opioid receptor in feeding. Peptides 4:797–800. https://doi.org/10.1016/0196-9781(83)90069-4
Morley JE, Levine AS, Yim GK, Lowy MT (1983) Opioid modulation of appetite. Neurosci Biobehav Rev 7:281–305. https://doi.org/10.1016/0149-7634(83)90020-9
Neal CR Jr, Mansour A, Reinscheid R, Nothacker HP, Civelli O, Akil H, Watson SJ Jr (1999) Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system: comparison of ORL1 receptor mRNA expression with (125)I-[(14)Tyr]-orphanin FQ binding. J Comp Neurol 412:563–605. https://doi.org/10.1002/(SICI)1096-9861(19991004)412:4<563::AID-CNE2>3.0.CO;2-Z
Novelle MG, Dieguez C (2018) Food addiction and binge eating: lessons learned from animal models. Nutrients 10. https://doi.org/10.3390/nu10010071
Olszewski PK, Levine AS (2004) Minireview: characterization of influence of central nociceptin/orphanin FQ on consummatory behavior. Endocrinology 145:2627–2632. https://doi.org/10.1210/en.2004-0016
Olszewski PK, Shaw TJ, Grace MK, Billington CJ, Levine AS (2000) Nocistatin inhibits food intake in rats. Brain Res 872:181–187. https://doi.org/10.1016/S0006-8993(00)02535-X
Olszewski PK, Grace MK, Sanders JB, Billington CJ, Levine AS (2002) Effect of nociceptin/orphanin FQ on food intake in rats that differ in diet preference. Pharmacol Biochem Behav 73:529–535. https://doi.org/10.1016/S0091-3057(02)00821-3
Olszewski PK et al (2010) Central nociceptin/orphanin FQ system elevates food consumption by both increasing energy intake and reducing aversive responsiveness. Am J Physiol Regul Integr Comp Physiol 299:R655–R663. https://doi.org/10.1152/ajpregu.00556.2009
Petrella C et al (2013) Protective and worsening peripheral nociceptin/orphanin FQ receptor-mediated effect in a rat model of experimental colitis. Pharmacol Res 70:72–79. https://doi.org/10.1016/j.phrs.2013.01.004
Pietras TA, Rowland NE (2002) Effect of opioid and cannabinoid receptor antagonism on orphanin FQ-induced hyperphagia in rats. Eur J Pharmacol 442:237–239. https://doi.org/10.1016/S0014-2999(02)01551-0
Placidi RJ, Chandler PC, Oswald KD, Maldonado C, Wauford PK, Boggiano MM (2004) Stress and hunger alter the anorectic efficacy of fluoxetine in binge-eating rats with a history of caloric restriction. Int J Eat Disord 36:328–341. https://doi.org/10.1002/eat.20044
Polidori C, Calo G, Ciccocioppo R, Guerrini R, Regoli D, Massi M (2000a) Pharmacological characterization of the nociceptin receptor mediating hyperphagia: identification of a selective antagonist. Psychopharmacology 148:430–437. https://doi.org/10.1007/s002130050073
Polidori C, de Caro G, Massi M (2000b) The hyperphagic effect of nociceptin/orphanin FQ in rats. Peptides 21:1051–1062. https://doi.org/10.1016/S0196-9781(00)00243-6
Pomonis JD, Billington CJ, Levine AS (1996) Orphanin FQ, agonist of orphan opioid receptor ORL1, stimulates feeding in rats. Neuroreport 8:369–371. https://doi.org/10.1097/00001756-199612200-00072
Pucci M et al (2016) Epigenetic regulation of nociceptin/orphanin FQ and corticotropin-releasing factor system genes in frustration stress-induced binge-like palatable food consumption. Addict Biol 21:1168–1185. https://doi.org/10.1111/adb.12303
Reinscheid RK et al (1995) Orphanin FQ: a neuropeptide that activates an opioid-like G protein-coupled receptor. Science 270:792–794. https://doi.org/10.1126/science.270.5237.792
Rinaldi-Carmona M et al (1994) SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350:240–244. https://doi.org/10.1016/0014-5793(94)00773-X
Rizzi A et al (2002) Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)NH2 analogues. 2. In vivo studies. Naunyn Schmiedeberg’s Arch Pharmacol 365:450–456. https://doi.org/10.1007/s00210-002-0549-7
Rizzi A et al (2007a) Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrah ydro-5H-benzocyclohepten-5-ol]: in vivo studies. J Pharmacol Exp Ther 321:968–974. https://doi.org/10.1124/jpet.106.116780
Rizzi A et al (2007b) In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor. Peptides 28:1240–1251. https://doi.org/10.1016/j.peptides.2007.04.020
Rodi D, Zucchini S, Simonato M, Cifani C, Massi M, Polidori C (2008) Functional antagonism between nociceptin/orphanin FQ (N/OFQ) and corticotropin-releasing factor (CRF) in the rat brain: evidence for involvement of the bed nucleus of the stria terminalis. Psychopharmacology 196:523–531. https://doi.org/10.1007/s00213-007-0985-7
Sanger DJ, McCarthy PS (1982) The anorectic action of naloxone is attenuated by adaptation to a food-deprivation schedule. Psychopharmacology 77:336–338. https://doi.org/10.1007/BF00432766
Schank JR, Ryabinin AE, Giardino WJ, Ciccocioppo R, Heilig M (2012) Stress-related neuropeptides and addictive behaviors: beyond the usual suspects. Neuron 76:192–208. https://doi.org/10.1016/j.neuron.2012.09.026
Shaw WN, Mitch CH, Leander JD, Mendelsohn LG, Zimmerman DM (1991) The effect of the opioid antagonist LY255582 on body weight of the obese Zucker rat. Int J Obes 15:387–395
Sobczak M, Cami-Kobeci G, Salaga M, Husbands SM, Fichna J (2014) Novel mixed NOP/MOP agonist BU08070 alleviates pain and inhibits gastrointestinal motility in mouse models mimicking diarrhea-predominant irritable bowel syndrome symptoms. Eur J Pharmacol 736:63–69. https://doi.org/10.1016/j.ejphar.2014.04.038
Statnick MA et al (2016) A novel nociceptin receptor antagonist LY2940094 inhibits excessive feeding behavior in rodents: a possible mechanism for the treatment of binge eating disorder. J Pharmacol Exp Ther 356:493–502. https://doi.org/10.1124/jpet.115.228221
Stengel A, Tache Y (2014) CRF and urocortin peptides as modulators of energy balance and feeding behavior during stress. Front Neurosci 8:52. https://doi.org/10.3389/fnins.2014.00052
Stratford TR, Holahan MR, Kelley AE (1997) Injections of nociceptin into nucleus accumbens shell or ventromedial hypothalamic nucleus increase food intake. Neuroreport 8:423–426. https://doi.org/10.1097/00001756-199701200-00009
van den Brandt J, Kovacs P, Kloting I (2000a) Features of the metabolic syndrome in the spontaneously hypertriglyceridemic Wistar Ottawa Karlsburg W (RT1u Haplotype) rat. Metab Clin Exp 49:1140–1144. https://doi.org/10.1053/meta.2000.8610
van Den Brandt J, Kovacs P, Kloting I (2000b) Metabolic variability among disease-resistant inbred rat strains and in comparison with wild rats (Rattus norvegicus). Clin Exp Pharmacol Physiol 27:793–795. https://doi.org/10.1046/j.1440-1681.2000.03336.x
Vergoni AV, Bertolini A (2000) Role of melanocortins in the central control of feeding. Eur J Pharmacol 405:25–32. https://doi.org/10.1016/S0014-2999(00)00538-0
Vitale G, Arletti R, Ruggieri V, Cifani C, Massi M (2006) Anxiolytic-like effects of nociceptin/orphanin FQ in the elevated plus maze and in the conditioned defensive burying test in rats. Peptides 27:2193–2200. https://doi.org/10.1016/j.peptides.2006.04.003
Vitale G et al (2017) Effects of [Nphe(1), Arg(14), Lys(15)] N/OFQ-NH2 (UFP-101), a potent NOP receptor antagonist, on molecular, cellular and behavioural alterations associated with chronic mild stress. J Psychopharmacol 31:691–703. https://doi.org/10.1177/0269881117691456
Voisey J, Carroll L, van Daal A (2003) Melanocortins and their receptors and antagonists. Curr Drug Targets 4:586–597. https://doi.org/10.2174/1389450033490858
Wagner EJ, Ronnekleiv OK, Grandy DK, Kelly MJ (1998) The peptide orphanin FQ inhibits beta-endorphin neurons and neurosecretory cells in the hypothalamic arcuate nucleus by activating an inwardly-rectifying K+ conductance. Neuroendocrinology 67:73–82. https://doi.org/10.1159/000054301
Wang L, Stengel A, Goebel M, Martinez V, Gourcerol G, Rivier J, Tache Y (2011) Peripheral activation of corticotropin-releasing factor receptor 2 inhibits food intake and alters meal structures in mice. Peptides 32:51–59. https://doi.org/10.1016/j.peptides.2010.10.017
Williams CM, Rogers PJ, Kirkham TC (1998) Hyperphagia in pre-fed rats following oral delta9-THC. Physiol Behav 65:343–346. https://doi.org/10.1016/S0031-9384(98)00170-X
Witkin JM et al (2014) The biology of nociceptin/orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence. Pharmacol Ther 141:283–299. https://doi.org/10.1016/j.pharmthera.2013.10.011
Zaratin PF et al (2004) Modification of nociception and morphine tolerance by the selective opiate receptor-like orphan receptor antagonist (-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahy dro-5H-benzocyclohepten-5-ol (SB-612111). J Pharmacol Exp Ther 308:454–461. https://doi.org/10.1124/jpet.103.055848
Zaveri N (2003) Peptide and nonpeptide ligands for the nociceptin/orphanin FQ receptor ORL1: research tools and potential therapeutic agents. Life Sci 73:663–678. https://doi.org/10.1016/S0024-3205(03)00387-4
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Micioni Di Bonaventura, M.V., Micioni Di Bonaventura, E., Cifani, C., Polidori, C. (2019). N/OFQ-NOP System in Food Intake. In: Ko, MC., Caló, G. (eds) The Nociceptin/Orphanin FQ Peptide Receptor. Handbook of Experimental Pharmacology, vol 254. Springer, Cham. https://doi.org/10.1007/164_2019_212
Download citation
DOI: https://doi.org/10.1007/164_2019_212
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-20185-2
Online ISBN: 978-3-030-20186-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)